GOPCABE: similar results for in-pump or off-pump surgery in elderly patients

Background: There is much debate about a possible benefit of coronary artery bypass grafting (CABG) without cardiopulmonary bypass (CPB) compared with on-pump surgery. However, a randomized study could not confirm this benefit. The objective of these studies was to compare the MACCE, (death, MI, stroke, revascularization repeated and a new dialysis), of surgical revascularization with and without cardiopulmonary bypass (CBP) in patients over 75 years. 

Methods and results: A multicenter study randomized 2,539 patients over 75 years of age to CABG with CBP and without CPB. At thirty days after surgery, there was no significant difference between patients who underwent off-pump surgery and those who underwent on-pump surgery in terms of the composite outcome, (7.8% versus 8.2%, odds ratio, 0.95, confidence interval 95% CI, 0.71 to 1.28, P = 0.74), or when analyzed separately for the four components, (death, stroke, myocardial infarction or new dialysis). Revascularization was more frequent after CABG with CPB, (1.3% versus 0.4%, odds ratio 2.42, 95% CI, 1.03 to 5.72, P = 0.04). At twelve months, there were no significant differences between groups in the composite outcome, (13.1% versus 14.0%, odds ratio 0.93, 95% CI, 0.76 to 1.16, P = 0, 48), or any of the individual components. 

Conclusion: The GOBCABE randomized study showed no significant difference between revascularization with or without cardiopulmonary bypass (CBP) at thirty days and one year. 

Comments: This study showed no differences between CABG surgery with or without CBP in a high-risk population (elderly) and, therefore, more exposed to pump complications. Cognitive status and quality of life after surgery was not assessed which is a limitation. There are many confusing variables that can occur even with the surgeon’s experience with this technique.

Loading...

Anno Diegeler
2013-03-11

Original title: The German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients (GOPCABE) Study. // Presentador:

More articles by this author

PARTNER cohort A at three years, the benefit continues

The PARTNER Cohort A randomized 699 elderly patients, (mean age 84.1), with severe aortic stenosis for TAVI or conventional surgery in 26 centers. The...

ASTRONAUT: Aliskiren failed to show benefits in patients with acute heart failure

Hospitalization for heart failure, (HF), represents a major health problem with high rates of death or early readmission after discharge. The aim of this...

RELAX Study: Phosphodieserase-5 inhibitors showed no benefit in heart failure with preserved ventricular function.

Phosphodieserase-5 enzyme is activated in heart failure and can limit the beneficial effects of nitric oxide, (NO), in the vasculature, kidney and myocardium. The...

STOP-HF: The use of B-type natriuretic peptide (BNP) for screening high-risk population decreases the prevalence of heart failure

B-type natriuretic peptide (BNP) can be a reliable marker for the diagnosis of heart failure (HF). This study aimed to assess whether the use...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Courtesy of Dr. Juan Manuel Pérez. Spontaneous left main dissection in an uncommon, and potentially life-threatening, cause of acute MI. The aim of this study,...

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...